Hook and thesis
Oracle sits at a stark crossroads. On one hand, the company is carrying a gargantuan remaining performance obligation (RPO) backlog - widely reported at about $638 billion - that underpins multi-year revenue visibility from AI data center buildouts and cloud infrastructure deals. On the other hand, the business is burning cash as it ramps capacity: reported free cash flow for the period is a negative $23.686 billion and management has signaled material capital raises and elevated capex ahead.
My view: this is a tactical buy. The backdrop of multi-year contracted revenue tied to AI workloads gives Oracle a rare combination of near-term growth visibility and scale. But treat this as a trade with explicit limits: enter near the current level, size the position to account for financing and execution risk, and use a clearly defined stop. If Oracle executes on backlog conversion without destructive dilution, the upside is meaningful; if the financing story gets messy or customer concentration stresses credit, downside will be swift.
What Oracle does and why the market should care
Oracle sells enterprise software and the cloud infrastructure that runs it, organized into Cloud and License, Hardware, and Services. The critical change over the last 18 months has been its pivot to large-scale AI infrastructure: Oracle is selling cloud services and physical data center capacity to hyperscale AI customers. The market cares because those contracts are typically large, multi-year and sticky; when recognized, they materially accelerate revenue and incremental margin.
Concretely, headlines on 09/09/2026 and 09/08/2026 reported the company carrying a roughly $638 billion backlog - a number management is using to guide faster revenue recognition in the next two years. Oracle has stated plans to recognize approximately $77 billion from RPO in fiscal 2027 and scale to roughly $108 billion annually by fiscal 2028-2029 under one projection. That magnitude of contracted revenue can materially change growth trajectories for a company with a current market cap around $432.8 billion and an enterprise value of approximately $531.1 billion.
Key financial and market metrics (useful anchors)
- Current price: $150.28 (snapshot).
- Market cap: $432.8 billion; enterprise value: $531.13 billion.
- P/E: roughly 25.5; EV/EBITDA: ~16.7; EV/Sales: ~7.9.
- Reported free cash flow: -$23.686 billion (negative).
- Debt-to-equity: ~3.05, indicating leverage has risen as the company funds buildouts.
- Dividend per share: $0.50 quarterly; yield just above 1%.
Why the backlog matters - and the conversion risk
A $638 billion backlog is not just a headline; it implies contracted demand for hardware, racks, networking and services stretching over multiple years. If Oracle can convert a meaningful portion into recognized revenue with healthy margins, that supports rapid revenue and EPS growth versus the most recent base. That potential is why some bullish scenarios put ORCL far above current levels.
But conversion is not automatic. Execution matters: data center buildouts require capex, supply-chain coordination and customer-side funding. One reported concentration risk is that a single customer (widely cited coverage points to OpenAI) represents a very large share of the backlog. If that concentration tightens credit or slows recognition, growth could underperform the optimistic paths priced by bulls.
Valuation framing
At roughly $150 per share, Oracle trades at a P/E near 25.5 and EV/EBITDA around 16.7. Those multiples are higher than a typical mature software business because investors are valuing the future growth baked into the backlog. Historically, Oracle traded as a cash-generative licensing business with lower capex and higher free cash flow; today's valuation reflects a market that is assigning value to future AI-related revenue growth, not just legacy earnings.
Is that fair? It depends on execution. If Oracle realizes the backlog into recurring cloud revenue and margins reaccelerate, the stock can justify multiples currently being paid. If instead the company needs to dilute equity, extend large credit terms to customers, or fails to match cloud peers on operational metrics, the current multiples look expensive. The presence of negative free cash flow and announced plans for significant financing increases the stakes: growth is available, but it is being paid for upfront with cash and balance-sheet actions.
Trade plan - actionable rules
Trade direction: Long.
| Entry | Target | Stop | Horizon | Risk Level |
|---|---|---|---|---|
| $150.255 | $210.000 | $136.000 | long term (180 trading days) | medium |
Rationale: buy near $150 to own a piece of the backlog conversion story while capping downside with a stop at $136. The target of $210 assumes partial successful conversion, modest margin recovery and stabilization of financing/dilution concerns. The horizon is long term (180 trading days) because backlog conversion and data center revenue recognition are multi-quarter processes; this trade is not a short-term momentum play.
Catalysts (what could move shares higher)
- Quarterly results showing RPO-to-revenue conversion at or above management guidance and a clear schedule for recognition into FY2027 revenue (near-term catalyst around next quarterly release).
- Evidence of diversified customer mix within the backlog (less concentration by any single customer).
- Signs that capex is translating into higher utilization and gross margins on cloud infrastructure.
- Credit markets receptive to planned financing, or better-than-feared terms on any share sale or debt issuance.
Risks and counterarguments
- Cash burn and financing risk: Free cash flow is negative $23.686 billion, and reporting has highlighted very large capex for FY2026 ($55.7 billion reported) with projections near $70 billion in FY2027. Management has discussed up to $40 billion in debt and equity raises, including a $20 billion share sale. Equity dilution or onerous debt terms would compress per-share value.
- Customer concentration: Press coverage points to a very large share of the backlog tied to a single hyperscaler. If that customer slows orders, renegotiates, or faces its own funding constraints, Oracle's revenue and cash flow recognition could decelerate sharply.
- Execution risk on data center buildouts: Building and scaling AI-optimized infrastructure is operationally complex. Delays, supply-chain or reliability issues could push recognition timelines and compress margins.
- Valuation sensitivity: The company trades at elevated multiples relative to its legacy cash profile. If growth disappoints or markets re-rate AI names, downside could be pronounced from current levels.
- Counterargument - Why it could still be expensive: Even with a massive backlog, the market may price Oracle closer to a capital-intensive infrastructure company than a high-margin software incumbent until free cash flow stabilizes. That reclassification could sustain a valuation discount and limit upside despite revenue growth.
What would change my view
I would upgrade the trade to a core, multi-year buy if Oracle reports two sequential quarters showing strong RPO-to-revenue conversion, improving free cash flow (moving toward neutral) and evidence of reduced customer concentration in the backlog. Conversely, I would move to sell or avoid if management proceeds with large equity issuance near current prices without accompanying margin or cash-flow improvement, or if RPO conversion timelines slip materially beyond management guidance.
Final take
Oracle's position in the AI infrastructure race gives it a rare growth runway for a company of its size. That opportunity justifies taking a measured long exposure at current prices for investors who are comfortable with elevated execution and financing risk. The trade is clear: buy around $150 with a disciplined stop at $136 and a 180-trading-day horizon to allow backlog conversion to show up in revenue. Stay attentive to quarterly cash flow, capex pacing and any financing announcements - those items will determine whether Oracle's backlog is a long-term gift or a short-term balance-sheet headache.
Note: This is a trade idea focused on an actionable entry, target and stop; size positions relative to portfolio risk tolerance and monitor catalysts closely.